Woodline Partners LP Sqz Biotechnologies CO Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.01 - $10.42 $207,164 - $538,318
-51,662 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.07 - $29.9 $623,560 - $1.54 Million
51,662 New
51,662 $707,000

Others Institutions Holding SQZ

# of Institutions
3
Shares Held
1.47M
Call Options Held
0
Put Options Held
0
View Full List

About SQZ Biotechnologies Co

SQZ Quotes by TradingView
  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email